Codagenix in vaccine tech licensing deal with Stony Brook

Stony Brook University and Codagenix researchers in the Stony Brook laboratory of Dr. Eckard Wimmer, center. From left, Steven Skiena, Rob Coleman, Steffen Mueller and Charles Stauft, who holds a Zika virus assay. (Credit: Stony Brook University)

A Farmingdale-based startup has secured exclusive rights to a technology developed at Stony Brook University that could spur the creation of new vaccines for influenza, Zika and other diseases, officials said Wednesday.

Codagenix Inc. has signed a 20-year licensing agreement with the university for use of a software algorithm that weakens a virus by changing its DNA. The weakened virus is...